US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 13.730
  • +0.150+1.10%
Trading Apr 26 15:04 ET
826.30MMarket Cap-1636P/E (TTM)

About Sage Therapeutics Company

SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.

Company Profile

SymbolSAGE
Company NameSage Therapeutics
Listing DateJul 18, 2014
Issue Price18.00
Founded2010
CEOMr. Barry E. Greene
MarketNASDAQ
Employees487
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address215 1st Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-299-8380
Websitehttp://www.sagerx.com

Company Executives

  • Name
  • Position
  • Salary
  • Barry E. Greene
  • Director, President and Chief Executive Officer
  • 6.24M
  • Christopher Benecchi
  • Chief Commercial Officer
  • 2.28M
  • Laura Gault
  • Chief Medical Officer
  • 1.27M
  • Kimi Iguchi
  • Chief Financial Officer and Principal Accounting Officer
  • 1.98M
  • Anne Marie Cook,Esq.
  • Senior Vice President, General Counsel, Secretary
  • 2.15M
  • Geno J. Germano
  • Chairman of the Board
  • 417.55K
  • Jessica J. Federer
  • Director
  • 962.23K
  • Dr. Jeffrey M. Jonas,M.D.
  • Director
  • 496.54K
  • Dr. George Golumbeski, PhD
  • Independent Director
  • 412.55K
  • James M. Frates
  • Independent Director
  • 435.05K
  • Dr. Steven M. Paul, M.D.
  • Independent Director
  • 420.05K
  • Elizabeth Barrett
  • Independent Director
  • 425.05K
  • Michael F. Cola
  • Independent Director
  • 440.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg